Roche Holding AG <a href="https://www.reuters.com/companies/ROG.S" target="_blank">(ROG.S)</a> said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its monoclonal antibody for treating COVID-19 in hospitalized adult patients.